This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Melo, S.A. et al. Nat. Genet. 41, 365–370 (2009).
Ionov, Y. et al. Nature 363, 558–561 (1993).
Jinek, M. & Doudna, J.A. Nature 457, 405–412 (2009).
Markowitz, S. et al. Science 268, 1336–1338 (1995).
Rampino, N. et al. Science 275, 967–969 (1997).
Mori, Y. et al. Cancer Res. 61, 6046–6049 (2001).
Woerner, S.M. et al. Oncogene 24, 2525–2535 (2005).
Caldes, T. et al. Int. J. Cancer 98, 774–779 (2002).
Caldés, T. et al. Oncol. Rep. 12, 621–629 (2004).
Sánchez de Abajo, A. et al. World J. Gastroenterol. 11, 5770–5776 (2005).
Acknowledgements
The present study was supported by Instituto de Salud Carlos III (ISCIII) research grants RD06/0020/0021, FIS07/0359 and FIS09/00859 from the Spanish Ministry of Science and Innovation.
Author information
Authors and Affiliations
Contributions
Experiments were designed by M.d.l.H. Experiments were performed and overseen by P.G., T.C. and M.d.l.H. Data was analyzed by P.G., T.C. and M.d.l.H. Clinical and molecular characterization of MSI-HNPCC tumors was performed by P.P.-S., E.D.-R. and T.C. The manuscript was written by M.d.l.H and P.G., with input from all other authors.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Methods, Supplementary Figures 1 and 2 and Supplementary Table 1 (PDF 382 kb)
Rights and permissions
About this article
Cite this article
Garre, P., Pérez-Segura, P., Díaz-Rubio, E. et al. Reassessing the TARBP2 mutation rate in hereditary nonpolyposis colorectal cancer. Nat Genet 42, 817–818 (2010). https://doi.org/10.1038/ng1010-817
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng1010-817
This article is cited by
-
Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study
Acta Neuropathologica (2020)
-
The role of TARBP2 in the development and progression of cancers
Tumor Biology (2016)
-
MicroRNA biogenesis pathways in cancer
Nature Reviews Cancer (2015)
-
MicroRNA regulation by RNA-binding proteins and its implications for cancer
Nature Reviews Cancer (2011)
-
Reply to “Reassessing the TARBP2 mutation rate in hereditary nonpolyposis colorectal cancer”
Nature Genetics (2010)